Together, these results indicated that CCN2 binding with LRP6 is a HSPGs-dependent process in HCC, and these findings are critical for us to develop treatment regimens to downregulation of Wnt signaling and inhibition of stemness of HCC, for those with high expression of CCN2. This evidence concerns the gene CCN2 and hepatocellular carcinoma.